-
About
Mass General- Hospital Overview
- Why Mass General
- In the Local & Global Community
- Massachusetts General Physicians Organization
- Multimedia
- News & Events
- Support Mass General
- Conditions
& Treatments- View All Conditions & Treatments
- View by Medical Category:
- Centers
& Services- Care Centers
- Departments
- Anesthesia, Critical Care
& Pain Medicine - Dermatology
- Emergency Medicine
- Imaging
- Medicine
- Molecular Biology
- Neurology
- Neurosurgery
- Obstetrics & Gynecology
- Anesthesia, Critical Care
- Facilities & Amenities
- Patient & Family Services
- Research
- View All Research Centers & Labs
- Research at Mass General
- Research News & Events
-
Clinical
Trials - Education
& Training- View All Fellowships, Residencies & CME
- Specialized Education & Training
- Education & Training Calendar
- Career
Opportunities
Eunice L. Kwak, MD, PhD
- Phone: 617-724-4000
- Departments
- Hematology/Oncology
- Department of Medicine
Specialties
- Cancer Center
- Stomach Cancer
- Gastrointestinal Cancers
- Colorectal Cancer
- Clinical Interests
- Hereditary cancer syndromes
- Gastrointestinal cancer
- Locations
- Boston: Massachusetts General Hospital
- Medical Education
- MD, Duke University School of Medicine
- PhD, Stanford University
- Residency, Brigham and Women's Hospital
- Fellowship, Dana-Farber Cancer Institute
- Board Certifications
- Medical Oncology, American Board of Internal Medicine
- Gender
- Female
- Patient Age Group
- Adult
- Accepting New Patients
- Yes
SAC meeting to honor past scientific leadership, address current challenges
ALL MGHERS are invited to attend the 2011 meeting of the MGH Scientific Advisory Committee (SAC), which will commemorate the hospital’s bicentennial with a look back at significant research accomplishments of MGH investigators and examine challenges facing today’s research community.
Celebrating prize-winning MGH research
The presentation of the MGH's top research prizes was a highlight of the April 13 Celebration of Science, held in conjunction with the annual Scientific Advisory Committee meeting.
New targeted lung cancer drug produces 'dramatic' symptom improvement
A clinical trial of a potential new targeted treatment drug has provided powerful evidence that it can halt or reverse the growth of lung tumors characterized by alterations in the anaplastic lymphoma kinase (ALK) gene.
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Phone 2: 617-726-6254
Fax: 617-726-0452
- © 2013 Massachusetts General Hospital
- 55 Fruit Street, Boston, MA 02114
- Maps & Directions
- 617-726-2000
- TDD: 617-724-8800
